Rajaie Cardiomyopathy and Myocarditis Registry
Launched by RAJAIE CARDIOVASCULAR MEDICAL AND RESEARCH CENTER · Mar 7, 2020
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Rajaie Cardiomyopathy and Myocarditis Registry is a study aimed at understanding different types of heart conditions known as cardiomyopathies, as well as myocarditis, which is inflammation of the heart muscle. The researchers are gathering information about the characteristics of these conditions, how they develop over time, the treatments currently being used, and how well those treatments work in the long term. This study is important because it seeks to improve our understanding and prediction of outcomes for patients with these heart issues, using advanced tools like artificial intelligence to help assess risk and treatment responses.
If you or a family member is over the age of one and has been diagnosed with one of the specific types of cardiomyopathy or myocarditis, you may be eligible to participate in this study. Participants will need to give their consent, or a parent will need to consent for children. By joining the registry, individuals will contribute to important research that could lead to better treatment options and outcomes for patients with these heart conditions. The study is currently looking for participants, and all genders are welcome to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age greater than one year
- • 2. documented cardiomyopathy/ myocarditis fulfilling standard diagnostic criteria
- • 3. able to give informed consent or in the case of child consent from a parent
- Exclusion Criteria:
- • Patients who have not consent to participate in the study.
About Rajaie Cardiovascular Medical And Research Center
The Rajaie Cardiovascular Medical and Research Center is a leading institution dedicated to advancing cardiovascular health through innovative research, clinical excellence, and comprehensive patient care. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing and evaluating new therapies for cardiovascular diseases. It is committed to fostering collaboration among healthcare professionals, researchers, and industry partners to enhance the understanding and treatment of cardiovascular conditions, ultimately improving patient outcomes and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tehran, , Iran, Islamic Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials